Ovation owns a unique population-scale biobank of consented and linkable disease-specific biospecimens, which includes more than 1.6 million samples from over...
Industry Conference Focused on Overcoming Healthcare Policy, Economic, and Business Hurdles in Go-to-Market Decisioning and Net Revenue Optimization PHILADELPHIA, Sept....
LEUVEN, Belgium, Sept. 5, 2024 /PRNewswire/ -- P95 BV ("P95"), a leading global provider of epidemiology and clinical solutions with a specialty...
Moderna's updated COVID-19 mRNA vaccine will be available for the 2024-2025 vaccination season, pending a European Commission authorization decision CAMBRIDGE,...
Project Funding Exceeds $7.0 MillionDALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the...
Ventis Medical Introduces a Technologically Advanced and Affordable Ventilator That Fills an Unmet Need PRINCETON, NJ / ACCESSWIRE / September...
Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on...
Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18%Development of a novel antiviral compound, XR8-23 (Compound 10),...
10 patients have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial Cohort...
CAMBRIDGE, MA / ACCESSWIRE / September 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Taiwan Food & Drug...
- Based on a per-protocol interim analysis of safety and efficacy data, the Independent Data Monitoring Committee (IDMC) recommended that...
Vancouver, British Columbia--(Newsfile Corp. - August 30, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks...
SHENZHEN, China, Aug. 29, 2024 /PRNewswire/ -- Dear Investors, Analysts and Media: Recently, UTime Ltd ("UTime") has experienced a period...
New campaign aims to inform and educate the public about the ongoing risks of COVID-19 and the impact the virus...
R&D Discussion in New York City to Review IL-12’s Potential to Treat Ovarian Cancer Program Features Ovarian Cancer Thought Leaders,...
Figure: 1 Elements of Ocean Biomedical Multi-pronged Malaria Program Testing Result Figure: 2 Dr. Jonathan Kurtis conducting research near Kisumu,...
- Seminar presentation at the invitation of Dx&Vx and Coree Group SEOUL, South Korea, Aug. 26, 2024 /PRNewswire/ -- Professor Wah...
SHELTON, CT / ACCESSWIRE / August 26, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader...
NEW YORK, Aug. 23, 2024 /PRNewswire/ -- The global clinical trial management system (CTMS) market size is estimated to grow by...